Insmed Inc. buy Wells Fargo & Company
Start price
23.03.26
/
50%
€126.00
Target price
23.03.27
€151.55
Performance (%)
-23.71%
Price
09:14
?
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -23.71%. This prediction currently runs until 23.03.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -3.075% | -3.075% |
| iShares Core DAX® | -1.596% | 1.524% |
| iShares Nasdaq 100 | 1.432% | 1.156% |
| iShares Nikkei 225® | 1.108% | 1.735% |
| iShares S&P 500 | 0.528% | 2.967% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) had its price target lowered by Wells Fargo & Company from $208.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat